Puma Biotechnology | PBYI - Ebit





Ebit Zmiana Data
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 3.83B 130M 2026-03
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Incyte USD 700.4M 356.23M 2026-06
MacroGenics USD -31.88M 19.79M 2026-03
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.73B 549M 2026-06
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Takeda JPY 201.42B 215.04B 2026-06
TG Therapeutics USD 34.8M 15.7M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03